BioNTech SE
(NAS:BNTX)
$
110.57
-0.07 (-0.06%)
Market Cap: 26.51 Bil
Enterprise Value: 8.23 Bil
PE Ratio: 0
PB Ratio: 1.25
GF Score: 68/100 BioNTech SE at Bank of America Merrill Lynch Healthcare Conference (Virtual) Transcript
May 14, 2020 / 03:40PM GMT
Release Date Price:
$48.66
(+0.35%)
Tazeen Ahmad
BofA Merrill Lynch, Research Division - VP
Good morning, everyone. Thanks for joining us at the Bank of America Healthcare Conference. I'm Tazeen Ahmad. I'm one of the senior biotech analysts here at the bank. It's my pleasure to introduce our next company BioNTech. Speaking for BioNTech this morning will be Ryan Richardson, Chief Strategy Officer. Good morning, Ryan.
Ryan Richardson
BioNTech SE - Chief Strategy Officer, MD & Member of Management Board
Good morning, Tazeen. Thank you very much for the invitation to join you today virtually. We'll be making some...
Tazeen Ahmad
BofA Merrill Lynch, Research Division - VP
You guys have the slide -- yes. So before I let you go into that, I'll -- yes, I'll let you -- everyone know that they can follow your slide deck, if they so choose. And I'll turn it right back over to you.
Ryan Richardson
BioNTech SE - Chief Strategy Officer, MD & Member of Management Board
Great, thank you. So I'll start on Page
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot